| Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria |
|
Blood |
Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Immunosuppression and Growth Factors for Severe Aplastic Anemia: New Data for Old Questions |
|
Haematologica |
Aplastic Anemia |
| Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry |
|
Annals of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro |
|
Experimental Hematology |
Myelodysplastic Syndromes (MDS) |
| Hematopoietic Cell Transplantation With Cryopreserved Grafts for Severe Aplastic Anemia |
|
Biology of blood and marrow transplantation: journal of the America Society of Blood and Marrow Transplantation |
Aplastic Anemia |
| Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? |
|
Best practice & research. Clinical haematology |
Myelodysplastic Syndromes (MDS) |
| SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM) |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide |
|
Blood Advances |
Aplastic Anemia |
| Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of |
|
Bone Marrow Transplantation |
Aplastic Anemia |
| Rewriting the rules for care of MDS and AML patients in the time of COVID-19 |
|
Leukemia Research Reports |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
